Invesco Large Cap Growth ETF (PWB) seeks to track the Dynamic Large Cap Growth Intellidex Index, which measures the performance of large-capitalization U.S. stocks exhibiting strong growth characteristics. This equity ETF focuses on companies demonstrating accelerating earnings growth, rising profit margins, and increasing sales momentum within the large-cap universe.
How It Works
PWB uses a rules-based methodology that screens large-cap U.S. stocks for specific growth metrics including earnings growth acceleration, profit margin expansion, and sales growth trends. The fund employs equal weighting rather than market-cap weighting, giving each qualifying stock the same initial allocation regardless of company size. Holdings are rebalanced quarterly to maintain equal weights and refresh the growth screen. The portfolio typically holds 50-100 stocks concentrated in growth-oriented sectors like technology and healthcare.
Key Features
- Equal-weighting methodology reduces concentration risk compared to cap-weighted growth ETFs dominated by mega-cap technology stocks
- Dynamic screening process focuses on growth acceleration rather than static metrics, potentially capturing emerging growth stories
- Quarterly rebalancing ensures fresh exposure to companies meeting current growth criteria while trimming momentum losers
Risks
- This ETF can lose value significantly during growth stock selloffs, potentially declining 40-50% when investors rotate from growth to value
- Equal weighting creates higher turnover and transaction costs compared to passive cap-weighted alternatives, potentially dragging returns
- Growth stock concentration means vulnerability to interest rate increases, which make future earnings less valuable and growth premiums unsustainable
Who Should Own This
Best suited for aggressive growth investors with 3-7 year time horizons seeking diversified large-cap growth exposure beyond mega-cap technology dominance. High risk tolerance required due to growth stock volatility. Works as a satellite holding representing 10-25% of equity allocation for investors wanting equal-weighted growth exposure.